Turalio Capsule
Product Images NDC 65597-407

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Turalio (NDC 65597-407). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Daiichi Sankyo Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Turalio 01)

Chemical Structure (Turalio 01)
Chemical structure of pexidartinib hydrochloride, the active ingredient in Turalio. The structure includes a chlorinated indole ring, a pyridine ring, and a trifluoromethyl-substituted pyridine ring, with a hydrogen chloride molecule indicated.*
FDA Label Image

Figure 1 (Turalio 02)

Figure 1 (Turalio 02)
A bar chart comparing percent change from baseline in tumor response between Turalio (pexidartinib hydrochloride) and placebo groups. The x-axis lists patients, and the y-axis shows percentage change from baseline in the affected joint. Bars indicate individual patient responses, with black bars for responders and white bars for non-responders. Turalio group shows mostly positive improvement percentages, while placebo group shows varied results including negative changes. Tumor response assessed by RECIST v1.1.*
FDA Label Image

Principal Display Panel (125 mg Capsule Bottle Carton)

Principal Display Panel (125 mg Capsule Bottle Carton)
Packaging label for Turalio 125 mg capsules, containing pexidartinib hydrochloride. The box indicates 120 capsules per package with instructions to take with a low-fat meal. Labeler is Daiichi Sankyo Inc. The label includes storage instructions, barcode, and lot/expiration placeholders, with the product name and strength prominently displayed.*
FDA Label Image

Principal Display Panel (125 mg Capsule Bottle Carton)

Principal Display Panel (125 mg Capsule Bottle Carton)
Packaging label for Turalio (pexidartinib) capsules 125 mg by Daiichi Sankyo Inc. The carton denotes 28 capsules with directions to take with a low-fat meal and reminds pharmacists to dispense the Medication Guide. The label includes storage instructions, manufacturing details, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.